Neurocrine Biosciences, Inc. (LON:0K6R)
London · Delayed Price · Currency is GBP · Price in USD 142.82
+2.90 (2.07%)
At close: Sep 17, 2025
Neurocrine Biosciences Employees
Neurocrine Biosciences had 1,800 employees as of December 31, 2024. The number of employees increased by 400 or 28.57% compared to the previous year.
Employees
1,800
Change (1Y)
400
Growth (1Y)
28.57%
Revenue / Employee
1.02M GBP
Profits / Employee
141.24K GBP
Market Cap
10.36B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,800 | 400 | 28.57% |
| Dec 31, 2023 | 1,400 | 200 | 16.67% |
| Dec 31, 2022 | 1,200 | 300 | 33.33% |
| Dec 31, 2021 | 900 | 55 | 6.51% |
| Dec 31, 2020 | 845 | 145 | 20.71% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| ConvaTec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| HUTCHMED (China) | 1,811 |
| Genus | 3,500 |
Neurocrine Biosciences News
- 8 days ago - Neurocrine Biosciences, Inc. (NBIX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 12 days ago - RBC Capital Raises Price Target for NBIX to $149, Maintains Outperform Rating | NBIX Stock News - GuruFocus
- 12 days ago - NBIX: Morgan Stanley Adjusts Price Target to $163 Amid Overweight Rating | NBIX Stock News - GuruFocus
- 14 days ago - Neurocrine Biosciences, Inc. (NBIX) Presents At Cantor Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 22 days ago - Neurocrine Biosciences to Present at Upcoming Investor Conferences in September - PRNewsWire
- 6 weeks ago - Neurocrine Biosciences to Present at the Canaccord Genuity 45th Annual Growth Conference - PRNewsWire
- 6 weeks ago - Neurocrine (NBIX) Q2 2025 Earnings Call Transcript - The Motley Fool
- 6 weeks ago - Neurocrine (NBIX) Q2 Revenue Jumps 17% - The Motley Fool